Home
DNA Learning Center
Preparing students and families to thrive in the gene age
programs
websites
resources
about
Website Search
ID 15714
Brian Druker
Description:
Brian Druker is a professor at Oregon Health Sciences University.
Keywords:
chronic myeloid leukemia,oregon health sciences university,oregon health sciences,health sciences university,brian druker,gleevec,cml,leukemia
This work by
Cold Spring Harbor Laboratory
is licensed under a
Creative Commons Attribution-Noncommercial-No Derivative Works 3.0 United States License
.
Related content:
15712. Bud and Yvonne
Bud and Yvonne are delighted by Bud's recovery thanks to Gleevec
SOURCE: DNAi
15055. Using DNA science to control CML, Brian Druker
Brian Druker talks about how the drug he designed targets the molecular cause of CML.
SOURCE: DNAi
15057. Before and after Gleevec, Brian Druker
Brian Druker talks about the drug he developed as a turning point in the war on cancer.
SOURCE: DNAi
15054. Restoring hope with Gleevec, Brian Druker
Brian Druker talks about how Gleevec has restored patients' hope for the future.
SOURCE: DNAi
15056. Approval for Gleevec in record time, Brian Druker
Brian Druker credits the drug company Novartis with recognizing the importance of Gleevec and accelerating the development and approval process.
SOURCE: DNAi
15082. Shutting down cancer with Gleevec, Brian Druker
Brian Druker reflects on the importance of understanding the causes of cancer for developing new treatments.
SOURCE: DNAi
15994. The chronic myeloid leukemia (CML) mutation
View the animation to learn about the Philadelphia chromosome, the abnormal chromosome that causes chronic myeloid leukemia.
SOURCE: DNAi
15042. The first day of clinical trials for Gleevec, Bud and Yvonne
Yvonne, Bud's wife, talks about the first day of the clinical trials in June of 1998.
SOURCE: DNAi
16109. Sense of urgency, Brian Druker
Brian Druker talks about sense of urgency.
SOURCE: DNAi
15041. Getting the diagnosis of chronic myeloid leukemia, Bud
Bud recounts receiving the diagnosis that he had chronic myeloid leukemia.
SOURCE: DNAi
CSHL Home
About CSHL
Research
Education
News & Features
Campus & Public Events
Careers
Giving